Advancing GvHD prevention with Tregs: clinical insights and manufacturing solutions
Advancing GvHD prevention with Tregs: clinical insights and manufacturing solutions
About the training
This webinar introduces the clinical application of regulatory T cells (Tregs) for graft-versus-host disease (GvHD) prevention and outlines how standardized technologies enable scalable and reproducible manufacturing workflows.
Participants will explore clinical insights from pediatric and adult settings, key manufacturing and analytical challenges, and how standardized workflows support process consistency. The session will also present technology solutions that enable robust and reproducible CGT manufacturing.
Tregs hold strong therapeutic potential, but clinical translation is challenged by complex processes and variability. Robust enrichment strategies and comprehensive analytical controls are key to ensuring consistent product quality.
Agenda:
- Clinical perspective: Use of Tregs for GvHD prevention in pediatric and adult patients
- Key manufacturing challenges: Complexity, variability, and requirements for reproducible workflows
- Technology and workflow solutions: Application of CliniMACS® Plus and integrated analytical tools for robust enrichment and process control
- Towards standardization: Strategies for reproducible Treg manufacturing to support clinical translation
APAC/EMEA session: Tuesday, September 15, 2026 I 10:00–11:00 a.m. CEST
Americas/EMEA session: Wednesday, September 16, 2026 I 5:00–6:00 p.m. CEST
Learning objectives
- Understand the clinical application of Tregs in GvHD prevention for pediatric and adult patients
- Identify key manufacturing and analytical challenges in Treg manufacturing
- Explore approaches to achieve robust and reproducible Treg workflows

Presenters
Prof. Antonio Pierini, PhD
Associate Professor, University of Perugia
Antonio Pierini is an Associate Professor of Hematology at the University of Perugia and Director of Hematopoietic Stem Cell Transplantation Program at Perugia University Hospital. His work focuses on allogeneic stem cell transplantation, regulatory T cells, and strategies to prevent GvHD and improve outcomes in acute leukemia. He trained at Stanford University and is an internationally recognized investigator, with invited lectures at global congresses including ASH, EHA, and EBMT.
Silvia Iaia, PhD
Field Application Specialist, Flow Cytometry & Cell Sorting, Miltenyi Biotec
Silvia Iaia is a Field Application Specialist at Miltenyi Biotec with extensive experience in customer-facing technical support, application training, and on-site troubleshooting in flow cytometry and cell sorting. She is specialized in multiparameter flow cytometry, experimental optimization, and scientific communication with academic and clinical customers.
Annalisa Sforza
Clinical Application Specialist, Miltenyi Biotec
Annalisa Sforza holds a Master’s degree in Applied Biology for Biomedical Research. She has experience in cardiovascular research, regenerative medicine, and cell therapy process development with CD34+ stem cells and T cells. Since 2023, she has been working as a Clinical Application Specialist at Miltenyi Biotec, supporting CGT customers through training, process optimization, and on-site manufacturing support.
Training locations and dates
Sorry, there are no available training dates at the moment.
Please contact your sales representative or your local MITC to discuss potential scheduling.
Your Miltenyi University benefits
Access online courses anytime, anywhere.
Become an expert in standard and innovative applications.
Acquire broad expertise and a comprehensive skill set.
Let us know your thoughts!
You did not find the course you are looking for? Do you have questions or comments?